Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Elevance Health Publishes Q3 2026 Earnings Call Transcript

By Public Technologies
  • Elevance Health held its third-quarter 2026 earnings call October 21, attended by CEO Gail Boudreaux, CFO Mark Kaye and other executives.
  • Management raised full-year adjusted diluted earnings per share guidance to at least $29, reflecting operating outperformance and favorable nonoperating items.
  • The earnings baseline increased $0.75 to at least $26.75, supporting projected adjusted diluted earnings per share growth of at least 12% in 2027.
  • Quarterly adjusted diluted earnings per share reached $6.99, exceeding expectations; the consolidated benefit expense ratio improved 70 basis points to 90.6%.
  • Medicaid margins should improve in 2027 as reimbursement rates better reflect costs; underlying cost trends remained elevated but stable.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.